Dianyun L. Ren

Union Hospital
Wuhan, 430022, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

HDAC1 Regulates Acquired Resistance to EGFR Inhibitors through the TFCP2-NDRG1 Signaling Axis in Pancreatic Cancer.

HDAC1 Regulates Acquired Resistance to EGFR Inhibitors through the TFCP2-NDRG1 Signaling Axis in Pancreatic Cancer.

Journal: International journal of biological sciences

Published: January 06, 2026

E2F3 activates NF-κB signaling through TRIM26 mediated TAB1 ubiquitination in pancreatic cancer.

E2F3 activates NF-κB signaling through TRIM26 mediated TAB1 ubiquitination in pancreatic cancer.

Journal: International journal of biological sciences

Published: November 02, 2025

CK2-dependent degradation of CBX3 dictates replication fork stalling and PARP inhibitor sensitivity.

CK2-dependent degradation of CBX3 dictates replication fork stalling and PARP inhibitor sensitivity.

Journal: Science advances

Published: May 23, 2024

Ubiquitin ligase TRIM15 promotes the progression of pancreatic cancer via the upregulation of the IGF2BP2-TLR4 axis.

Ubiquitin ligase TRIM15 promotes the progression of pancreatic cancer via the upregulation of the IGF2BP2-TLR4 axis.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: November 30, 2023

Correction for: Using ESTIMATE algorithm to establish an 8-mRNA signature prognosis prediction system and identify immunocyte infiltration-related genes in Pancreatic adenocarcinoma.

Correction for: Using ESTIMATE algorithm to establish an 8-mRNA signature prognosis prediction system and identify immunocyte infiltration-related genes in Pancreatic adenocarcinoma.

Journal: Aging

Published: September 03, 2023

MST2 methylation by PRMT5 inhibits Hippo signaling and promotes pancreatic cancer progression.

MST2 methylation by PRMT5 inhibits Hippo signaling and promotes pancreatic cancer progression.

Journal: The EMBO journal

Published: May 19, 2023

ITGA2 induces STING expression in pancreatic cancer by inducing DNMT1 degradation.

ITGA2 induces STING expression in pancreatic cancer by inducing DNMT1 degradation.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: October 08, 2022

ITGA2 overexpression inhibits DNA repair and confers sensitivity to radiotherapies in pancreatic cancer.

ITGA2 overexpression inhibits DNA repair and confers sensitivity to radiotherapies in pancreatic cancer.

Journal: Cancer letters

Published: June 06, 2022

S-palmitoylation of PCSK9 induces sorafenib resistance in liver cancer by activating the PI3K/AKT pathway.

S-palmitoylation of PCSK9 induces sorafenib resistance in liver cancer by activating the PI3K/AKT pathway.

Journal: Cell reports

Published: January 01, 2022

HDAC5 Loss Enhances Phospholipid-Derived Arachidonic Acid Generation and Confers Sensitivity to cPLA2 Inhibition in Pancreatic Cancer.

HDAC5 Loss Enhances Phospholipid-Derived Arachidonic Acid Generation and Confers Sensitivity to cPLA2 Inhibition in Pancreatic Cancer.

Journal: Cancer research

Published: December 20, 2021

Clinical characteristics of perianal/perineal rhabdomyosarcoma-a report of 15 cases

Clinical characteristics of perianal/perineal rhabdomyosarcoma-a report of 15 cases

Journal: Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery

Published: December 19, 2021

SGLT2 inhibitor activates the STING/IRF3/IFN-β pathway and induces immune infiltration in osteosarcoma.

SGLT2 inhibitor activates the STING/IRF3/IFN-β pathway and induces immune infiltration in osteosarcoma.

Journal: Cell death & disease

Published: December 08, 2021

Showing 1-12 of 32

Last Updated: 09/26/2026